1. C–X–C motif chemokine ligand 12: a potential therapeutic target in Duchenne muscular dystrophy
   Jie Chen et al, 2021, Bioengineered CrossRef
2. CRISPR-Based Therapeutic Gene Editing for Duchenne Muscular Dystrophy: Advances, Challenges and Perspectives
   Guofang Chen et al, 2022, Cells CrossRef
3. Anti-inflammatory therapy enables robot-actuated regeneration of aged muscle
   S. L. McNamara et al, 2023, Science Robotics CrossRef
4. A Decade of Progress in Gene Targeted Therapeutic Strategies in Duchenne Muscular Dystrophy: A Systematic Review
   Lam Chung Liang et al, 2022, Frontiers in Bioengineering and Biotechnology CrossRef
5. Functional and Clinical Outcomes Associated with Steroid Treatment among Non-ambulatory Patients with Duchenne Muscular Dystrophy1
   Craig M. McDonald et al, 2023, Journal of Neuromuscular Diseases CrossRef
6. Puesta al día en distrofia muscular de Duchenne
   F. Leiva-Cepas et al, 2021, Medicina de Familia. SEMERGEN CrossRef
7. CRISPR-Editing Therapy for Duchenne Muscular Dystrophy
   Francesco Chemello et al, 2023, Human Gene Therapy CrossRef
8. Development of Essential Oil Delivery Systems by ‘Click Chemistry’ Methods: Possible Ways to Manage Duchenne Muscular Dystrophy
   Greta Kaspute et al, 2023, Materials CrossRef
9. Quantifying Variability in Motor Function in Duchenne Muscular Dystrophy: UK Centiles for the NorthStar Ambulatory Assessment, 10 m Walk Run Velocity and Rise from Floor Velocity in GC Treated Boys
   Georgia Stimpson et al, 2024, Journal of Neuromuscular Diseases CrossRef
10. Correction of human nonsense mutation via adenine base editing for Duchenne muscular dystrophy treatment in mouse
    Ming Jin et al, 2024, Molecular Therapy - Nucleic Acids CrossRef